Cargando…
Clinical, Biochemical, Molecular, and Outcome Features of Mitochondrial 3-Hydroxy-3-Methylglutaryl-CoA Synthase Deficiency in 10 Chinese Patients
Background: Mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase deficiency (HMGCS2D) is a rare autosomal recessive metabolic disorder caused by mutations of the HMGCS2 gene. To date, no more than 60 patients have been reported throughout the world. Purpose: To analyze the clinical, biochemical, mo...
Autores principales: | Wu, Shengnan, Shen, Linghua, Chen, Qiong, Gong, Chunxiu, Yang, Yanling, Wei, Haiyan, Cao, Bingyan, Chen, Yongxing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931749/ https://www.ncbi.nlm.nih.gov/pubmed/35308163 http://dx.doi.org/10.3389/fgene.2021.816779 |
Ejemplares similares
-
Cloning and Characterisation of the Gene Encoding 3-Hydroxy-3-Methylglutaryl-CoA Synthase in Tripterygium wilfordii
por: Liu, Yu-Jia, et al.
Publicado: (2014) -
Mutations underlying 3-Hydroxy-3-Methylglutaryl CoA Lyase deficiency in the Saudi population
por: Al-Sayed, Moeenaldeen, et al.
Publicado: (2006) -
Pan‐cancer analysis reveals the oncogenic role of 3‐hydroxy‐3‐methylglutaryl‐CoA synthase 1
por: Zhou, Cheng, et al.
Publicado: (2021) -
Novel HMGCS2 pathogenic variants in a Chinese family with mitochondrial 3‐hydroxy‐3‐methylglutaryl‐CoA synthase deficiency
por: Zhang, Pengfei, et al.
Publicado: (2019) -
A newborn screening approach to diagnose 3‐hydroxy‐3‐methylglutaryl‐CoA lyase deficiency
por: Václavík, Jan, et al.
Publicado: (2020)